Skip to main content
Erschienen in: International Ophthalmology 6/2018

31.10.2017 | Review

ILM peeling in nontractional diabetic macular edema: review and metanalysis

verfasst von: M. Rinaldi, R. dell’Omo, F. Morescalchi, F. Semeraro, E. Gambicorti, F. Cacciatore, F. Chiosi, C. Costagliola

Erschienen in: International Ophthalmology | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the effect of internal limiting membrane (ILM) peeling during vitrectomy for nontractional diabetic macular edema.

Methods

PUBMED, MEDLINE and CENTRAL were reviewed using the following terms (or combination of terms): diabetic macular edema, nontractional diabetic macular edema, internal limiting membrane peeling, vitrectomy, Müller cells. Randomized and nonrandomized studies were included. The eligible studies compared anatomical and functional outcomes of vitrectomy with or without ILM peeling for tractional and nontractional diabetic macular edema. Postoperative best-corrected visual acuity and central macular thickness were considered, respectively, the primary and secondary outcomes. Meta-analysis on mean differences between vitrectomy with and without ILM peeling was performed using inverse variance method in random effects.

Results

Four studies with 672 patients were eligible for analysis. No significant difference was found between postoperative best-corrected visual acuity or best-corrected visual acuity change of ILM peeling group compared with nonpeeling group. There was no significant difference in postoperative central macular thickness and central macular thickness reduction between the two groups.

Conclusions

The visual acuity outcomes in patients affected by nontractional diabetic macular edema using pars plana vitrectomy with ILM peeling versus no ILM peeling were not significantly different. A larger prospective and randomized study would be necessary.
Literatur
1.
Zurück zum Zitat Klein R, Klein BE, Moss SE, Cruickshanks KJ (1995) The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long term incidence of macular edema. Ophthalmology 102:7–16CrossRef Klein R, Klein BE, Moss SE, Cruickshanks KJ (1995) The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long term incidence of macular edema. Ophthalmology 102:7–16CrossRef
2.
Zurück zum Zitat Semeraro F, Cancarini A, dell’Omo R, Rezzola S, Romano MR, Costagliola C (2015) Diabetic retinopathy: vascular and inflammatory disease. J Diabetes Res 2015:582060CrossRef Semeraro F, Cancarini A, dell’Omo R, Rezzola S, Romano MR, Costagliola C (2015) Diabetic retinopathy: vascular and inflammatory disease. J Diabetes Res 2015:582060CrossRef
3.
Zurück zum Zitat Stehphen J. Ryan. Non proliferative diabetic retinopathy, Chap 67. In: Retina, Vol II, 4th edn. pp 1275–1276 Stehphen J. Ryan. Non proliferative diabetic retinopathy, Chap 67. In: Retina, Vol II, 4th edn. pp 1275–1276
4.
Zurück zum Zitat Dell’Omo R, Semeraro F, Bamonte G, Cifariello F, Romano MR, Costagliola C (2013) Vitreous mediators in retinal hypoxic diseases. Mediators Inflamm 2013:935301PubMedPubMedCentral Dell’Omo R, Semeraro F, Bamonte G, Cifariello F, Romano MR, Costagliola C (2013) Vitreous mediators in retinal hypoxic diseases. Mediators Inflamm 2013:935301PubMedPubMedCentral
5.
Zurück zum Zitat Agarwal D, Gelman R, Prospero Ponce C, Stevenson W, Christoforidis JB (2015) The vitreomacular interface in diabetic retinopathy. J Ophthalmol 2015:392983CrossRef Agarwal D, Gelman R, Prospero Ponce C, Stevenson W, Christoforidis JB (2015) The vitreomacular interface in diabetic retinopathy. J Ophthalmol 2015:392983CrossRef
6.
Zurück zum Zitat Bandello F, Lattanzio R, Zucchiatti I, Del Turco C (2013) Pathophysiology and treatment of diabetic retinopathy. Acta Diabetol 50:1–20CrossRef Bandello F, Lattanzio R, Zucchiatti I, Del Turco C (2013) Pathophysiology and treatment of diabetic retinopathy. Acta Diabetol 50:1–20CrossRef
7.
Zurück zum Zitat Abari E, Kociok N, Hartmann U, Semkova I, Paulsson M, Lo A, Joussen AM (2013) Alterations in basement membrane immunoreactivity of the diabetic retina in three diabetic mouse models. Graefes Arch Clin Exp Ophthalmol 251:763–775CrossRef Abari E, Kociok N, Hartmann U, Semkova I, Paulsson M, Lo A, Joussen AM (2013) Alterations in basement membrane immunoreactivity of the diabetic retina in three diabetic mouse models. Graefes Arch Clin Exp Ophthalmol 251:763–775CrossRef
8.
Zurück zum Zitat Semeraro F, Parrinello G, Cancarini A et al (2011) Predicting the risk of diabetic retinopathy in type 2 diabetic patients. J Diabetes Complications 25:292–297CrossRef Semeraro F, Parrinello G, Cancarini A et al (2011) Predicting the risk of diabetic retinopathy in type 2 diabetic patients. J Diabetes Complications 25:292–297CrossRef
9.
Zurück zum Zitat Rinaldi M, Chiosi F, dell’Omo R et al (2012) Intravitreal pegaptanib sodium (Macugen®) for treatment of diabetic macular oedema: a morphologic and functional study. Br J Clin Pharmacol 74:940–946CrossRef Rinaldi M, Chiosi F, dell’Omo R et al (2012) Intravitreal pegaptanib sodium (Macugen®) for treatment of diabetic macular oedema: a morphologic and functional study. Br J Clin Pharmacol 74:940–946CrossRef
10.
Zurück zum Zitat Bressler SB, Liu D, Glassman AR, Blodi BA, Castellarin AA, Jampol LM, Kaufman PL, Melia M, Singh H, Wells JA, Diabetic Retinopathy Clinical Research Network (2017) Change in diabetic retinopathy through 2 years: secondary analysis of a randomized clinical trial comparing aflibercept, bevacizumab, and ranibizumab. JAMA Ophthalmol 135(6):558–568CrossRef Bressler SB, Liu D, Glassman AR, Blodi BA, Castellarin AA, Jampol LM, Kaufman PL, Melia M, Singh H, Wells JA, Diabetic Retinopathy Clinical Research Network (2017) Change in diabetic retinopathy through 2 years: secondary analysis of a randomized clinical trial comparing aflibercept, bevacizumab, and ranibizumab. JAMA Ophthalmol 135(6):558–568CrossRef
11.
Zurück zum Zitat Khan Z, Kuriakose RK, Khan M, Chin EK, Almeida DR (2017) Efficacy of the intravitreal sustained-release dexamethasone implant for diabetic macular edema refractory to anti-vascular endothelial growth factor therapy: meta-analysis and clinical implications. Ophthal Surg Lasers Imaging Retina 48(2):160–166CrossRef Khan Z, Kuriakose RK, Khan M, Chin EK, Almeida DR (2017) Efficacy of the intravitreal sustained-release dexamethasone implant for diabetic macular edema refractory to anti-vascular endothelial growth factor therapy: meta-analysis and clinical implications. Ophthal Surg Lasers Imaging Retina 48(2):160–166CrossRef
12.
Zurück zum Zitat Syed YY (2017) Fluocinolone acetonide intravitreal implant 0.19 (ILUVIEN(®)): a review in diabetic macular edema. Drugs 77(5):575–583CrossRef Syed YY (2017) Fluocinolone acetonide intravitreal implant 0.19 (ILUVIEN(®)): a review in diabetic macular edema. Drugs 77(5):575–583CrossRef
13.
Zurück zum Zitat Yamamoto T, Naoko A, Takeuchi S (2001) Vitrectomy for diabetic macular oedema: the role of posterior vitreous detachment and epimacular membrane. Am J Ophthalmol 132:369–377CrossRef Yamamoto T, Naoko A, Takeuchi S (2001) Vitrectomy for diabetic macular oedema: the role of posterior vitreous detachment and epimacular membrane. Am J Ophthalmol 132:369–377CrossRef
14.
Zurück zum Zitat Diabetic retinopathy clinical research network writing committee, Haller JA, Qin H, Apte RS et al (2010) Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction. Opthtalmology 117:1087–1093CrossRef Diabetic retinopathy clinical research network writing committee, Haller JA, Qin H, Apte RS et al (2010) Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction. Opthtalmology 117:1087–1093CrossRef
15.
Zurück zum Zitat Ikeda T, Sato K, Katano T, Hayashi Y (1999) Vitrectomy for cystoid macular oedema with attached posterior hyaloid membrane in patients with diabetes. Br J Opthtalmol 83:12–14CrossRef Ikeda T, Sato K, Katano T, Hayashi Y (1999) Vitrectomy for cystoid macular oedema with attached posterior hyaloid membrane in patients with diabetes. Br J Opthtalmol 83:12–14CrossRef
16.
Zurück zum Zitat Hartley KL, Smiddy WE, Flynn HW Jr, Murray TG (2008) Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema. Retina 28:410–419CrossRef Hartley KL, Smiddy WE, Flynn HW Jr, Murray TG (2008) Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema. Retina 28:410–419CrossRef
17.
Zurück zum Zitat Ternent L, Vale L, Boachie C, Burr JM, Lois N, Full-Thickness Macular Hole and Internal Limiting Membrane Peeling Study (FILMS) Group (2012) Cost-effectiveness of internal limiting membrane peeling versus no peeling for patients with an idiopathic full-thickness macular hole: results from a randomised controlled trial. Br J Ophthalmol 96:438–443CrossRef Ternent L, Vale L, Boachie C, Burr JM, Lois N, Full-Thickness Macular Hole and Internal Limiting Membrane Peeling Study (FILMS) Group (2012) Cost-effectiveness of internal limiting membrane peeling versus no peeling for patients with an idiopathic full-thickness macular hole: results from a randomised controlled trial. Br J Ophthalmol 96:438–443CrossRef
18.
Zurück zum Zitat Hasegawa T, Emi K, Ikeda T, Watanabe M, Takaoka G (2004) Long-term prognosis of internal limiting membrane peeling for idiopathic epiretinal membrane. Nihon Ganka Gakkai Zasshi 108:150–156PubMed Hasegawa T, Emi K, Ikeda T, Watanabe M, Takaoka G (2004) Long-term prognosis of internal limiting membrane peeling for idiopathic epiretinal membrane. Nihon Ganka Gakkai Zasshi 108:150–156PubMed
19.
Zurück zum Zitat Park DW, Dugel PU, Garda J et al (2003) Macular pucker removal with and without internal limiting membrane peeling: pilot study. Ophthalmology 110:62–64CrossRef Park DW, Dugel PU, Garda J et al (2003) Macular pucker removal with and without internal limiting membrane peeling: pilot study. Ophthalmology 110:62–64CrossRef
20.
Zurück zum Zitat Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101CrossRef Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101CrossRef
21.
Zurück zum Zitat Bonnin S, Sandali O, Bonnel S, Monin C, el Sanharawi M (2015) Vitrectomy with internal limiting membrane peeling for tractional and non tractional diabetic macular edema: long-term results of a comparative study. Retina 35:921–928CrossRef Bonnin S, Sandali O, Bonnel S, Monin C, el Sanharawi M (2015) Vitrectomy with internal limiting membrane peeling for tractional and non tractional diabetic macular edema: long-term results of a comparative study. Retina 35:921–928CrossRef
22.
Zurück zum Zitat Ghassemi F, Bazvand F, Roohipoor R, Yaseri M, Hassanpoor N, Zarei M (2016) Outcomes of vitrectomy, membranectomy and internal limiting membrane peeling I patients with refractory diabetic macular edema and non-tractional epiretinal membrane. J Curr Ophthalmol 28:199–205CrossRef Ghassemi F, Bazvand F, Roohipoor R, Yaseri M, Hassanpoor N, Zarei M (2016) Outcomes of vitrectomy, membranectomy and internal limiting membrane peeling I patients with refractory diabetic macular edema and non-tractional epiretinal membrane. J Curr Ophthalmol 28:199–205CrossRef
23.
Zurück zum Zitat Kumagai K, Furukawa M, Ogino N, Larson E, Iwaki M, Tachi N (2009) Long-term follow-up of vitrectomy for diffuse nontractional diabetic macular edema. Retina 29:464–472CrossRef Kumagai K, Furukawa M, Ogino N, Larson E, Iwaki M, Tachi N (2009) Long-term follow-up of vitrectomy for diffuse nontractional diabetic macular edema. Retina 29:464–472CrossRef
24.
Zurück zum Zitat Kumagai K, Hangai M, Ogino N, Larson E (2015) Effect of internal limiting membrane peeling on long-term visual outcomes for diabetic macular edema. Retina 35:1422–1428CrossRef Kumagai K, Hangai M, Ogino N, Larson E (2015) Effect of internal limiting membrane peeling on long-term visual outcomes for diabetic macular edema. Retina 35:1422–1428CrossRef
25.
Zurück zum Zitat Patel JI, Hykin PG, Schadt M et al (2006) Pars plana vitrectomy with and without peeling of the inner limiting membrane for diabetic macular edema. Retina 26:5–13CrossRef Patel JI, Hykin PG, Schadt M et al (2006) Pars plana vitrectomy with and without peeling of the inner limiting membrane for diabetic macular edema. Retina 26:5–13CrossRef
26.
Zurück zum Zitat Figueroa MS, Contreras I, Noval S (2008) Surgical and anatomical outcomes of pars plana vitrectomy for diffuse non tractional diabetic macular edema. Retina 28:420–426CrossRef Figueroa MS, Contreras I, Noval S (2008) Surgical and anatomical outcomes of pars plana vitrectomy for diffuse non tractional diabetic macular edema. Retina 28:420–426CrossRef
27.
Zurück zum Zitat Gandorfer A, Messmer EM, Ulbig MW, Kampik A (2000) Resolution of diabetic macular edema after surgical removal of the posterior hyaloids and the inner limiting membrane. Retina 20:126–133CrossRef Gandorfer A, Messmer EM, Ulbig MW, Kampik A (2000) Resolution of diabetic macular edema after surgical removal of the posterior hyaloids and the inner limiting membrane. Retina 20:126–133CrossRef
28.
Zurück zum Zitat Diabetic Retinopathy Clinical Research Network Writing Committee, Haller JA, Qin H, Apte RS et al (2010) Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction. Ophthalmology 117(1087–1093):e3 Diabetic Retinopathy Clinical Research Network Writing Committee, Haller JA, Qin H, Apte RS et al (2010) Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction. Ophthalmology 117(1087–1093):e3
29.
Zurück zum Zitat Kumagai K, Ogino N, Furukawa M et al (2002) Internal limiting membrane peeling in vitreous surgery for diabetic macular edema. Nihon Ganka Gakkai Zasshi 106:590–594PubMed Kumagai K, Ogino N, Furukawa M et al (2002) Internal limiting membrane peeling in vitreous surgery for diabetic macular edema. Nihon Ganka Gakkai Zasshi 106:590–594PubMed
30.
Zurück zum Zitat Ikeda T, Sato K, Katano T, Hayashi Y (2000) Improved visual acuity following pars plana vitrectomy for diabetic cystoid macular edema and detached posterior hyaloid. Retina 20:220–222CrossRef Ikeda T, Sato K, Katano T, Hayashi Y (2000) Improved visual acuity following pars plana vitrectomy for diabetic cystoid macular edema and detached posterior hyaloid. Retina 20:220–222CrossRef
31.
Zurück zum Zitat La Heij EC, Hendrikse F, Kessels AG, Derhaag PJ (2001) Vitrectomy results in diabetic macular oedema without evident vitreomacular traction. Graefes Arch Clin Exp Ophthalmol 239:264–270CrossRef La Heij EC, Hendrikse F, Kessels AG, Derhaag PJ (2001) Vitrectomy results in diabetic macular oedema without evident vitreomacular traction. Graefes Arch Clin Exp Ophthalmol 239:264–270CrossRef
32.
Zurück zum Zitat Yanyali A, Bozkurt KT, Macin A, Horozoglu F, Nohutcu AF (2011) Quantitative assessment of photoreceptor layer in eyes with resolved edema after pars plana vitrectomy with internal limiting membrane removal for diabetic macular edema. Ophthalmologica 226:57–63CrossRef Yanyali A, Bozkurt KT, Macin A, Horozoglu F, Nohutcu AF (2011) Quantitative assessment of photoreceptor layer in eyes with resolved edema after pars plana vitrectomy with internal limiting membrane removal for diabetic macular edema. Ophthalmologica 226:57–63CrossRef
33.
Zurück zum Zitat Bahadir M, Ertan A, Mertoğlu O (2005) Visual acuity comparison of vitrectomy with and without internal limiting membrane removal in the treatment of diabetic macular edema. Int Ophthalmol 26:3–8CrossRef Bahadir M, Ertan A, Mertoğlu O (2005) Visual acuity comparison of vitrectomy with and without internal limiting membrane removal in the treatment of diabetic macular edema. Int Ophthalmol 26:3–8CrossRef
34.
Zurück zum Zitat Yanyali A, Horozoglu F, Celik E, Nohutcu AF (2007) Long-term outcomes of pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema. Retina 27:557–566CrossRef Yanyali A, Horozoglu F, Celik E, Nohutcu AF (2007) Long-term outcomes of pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema. Retina 27:557–566CrossRef
Metadaten
Titel
ILM peeling in nontractional diabetic macular edema: review and metanalysis
verfasst von
M. Rinaldi
R. dell’Omo
F. Morescalchi
F. Semeraro
E. Gambicorti
F. Cacciatore
F. Chiosi
C. Costagliola
Publikationsdatum
31.10.2017
Verlag
Springer Netherlands
Erschienen in
International Ophthalmology / Ausgabe 6/2018
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-017-0761-6

Weitere Artikel der Ausgabe 6/2018

International Ophthalmology 6/2018 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Die überschießende Wundheilung in der filtrierenden Glaukomchirurgie ist ein zentraler Faktor für ein operatives Versagen. Nach der Einführung der Trabekulektomie in den 1960er-Jahren wurden viele Faktoren erkannt, die mit einer vermehrten …

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.